| Literature DB >> 29915338 |
Mei Zhu1, Yu Xu1, Huawei Wang2, Zongwen Shen1,3, Zhenrong Xie1,4, Fengrong Chen1,4, Yunhong Gao5,6, Xin Chen5,6, Ying Zhang5,6, Qiang Wu5,6, Xuejun Li5,6, Juehua Yu1, Huayou Luo7, Kunhua Wang8.
Abstract
Repeated administration of heroin results in the induction of physical dependence, which is characterized as a behavioral state of compulsive drug seeking and a high rate of relapse even after periods of abstinence. However, few studies have been dedicated to characterization of the long-term alterations in heroin-dependent patients (HDPs). Herein, we examined the peripheral blood from 810 HDPs versus 500 healthy controls (HCs) according to the inclusion criteria. Compared with the control group, significant decreases of albumin, triglyceride, and total cholesterol levels were identified in HDPs (P < 0.001) versus HCs coupled with an insignificant decrease in BMI. Meanwhile, RNA-sequencing analyses were performed on blood of 16 long-term HDPs and 25 HCs. The results showed that the TNFα signaling pathway and hematopoiesis related genes were inhibited in HDPs. We further compared the transcriptome data to those of SCA2 and posttraumatic stress disorder patients, identified neurodegenerative diseases related genes were commonly up-regulated in coupled with biological processes "vesicle transport", "mitochondria" and "splicing". Genes in the categories of "protein ubiquitination" were down-regulated indicating potential biochemical alterations shared by all three comparative to their controls. In summary, this is a leading study performing a series of through investigations and using delicate approaches. Results from this study would benefit the study of drug addiction overall and link long-term heroin abuse to neurodegenerative diseases.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29915338 PMCID: PMC6006288 DOI: 10.1038/s41598-018-27419-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Overall experimental design for 2009 subjects including 1509 male HDPs and 500 male HCs in this study.
Characteristics of healthy controls (HCs) and heroin-dependent patients (HDPs).
| Study data | HCs | HDPs | p-value |
|---|---|---|---|
|
| |||
| No. of subjects | 500 | 1509 | NA |
| Sex | 500 M/0 F | 1509 M/0 F | NA |
| Age, y | 36.0 ± 9.3 (20–58) | 35.1 ± 8.1 (18–58) | 0.734 |
| BMI, kg/m2 | 25.3 ± 3.2 | 23.8 ± 3.8 | 0.232 |
| Duration of heroin-use, mo | NA | 93.3 ± 73.5 (1–420) | NA |
|
| |||
| No. of subjects | 500 | 810 | NA |
| Sex | 500 M/0 F | 810 M/0 F | NA |
| Age, y | 36.0 ± 9.3 (20–58) | 33.9 ± 8.4 (18–56) | 0.569 |
| BMI, kg/m2 | 25.3 ± 3.2 | 23.6 ± 3.7 | 0.158 |
| Duration of heroin-use, mo | NA | 77.3 ± 65.9 (1–420) | NA |
Figure 2Characteristics of the routes of heroin administration and the average duration of heroin use in these HDPs. (A) The routes of heroin administration in all 1509 HDPs; (B and C) the percentage and actual number of HDPs with various duration of heroin use in all 1509 HDPs; (D) the routes of heroin administration in 810 enrolled HDPs; (E and F) the percentage and actual number of HDPs with various duration of heroin use in 810 enrolled HDPs.
Characteristics of healthy controls (HCs), long-term heroin-dependent patients (Long-HDPs) and short-term heroin-dependent patients (Short-HDPs).
| Study data | HCs | Long-HDPs | Short-HDPs |
|---|---|---|---|
| No. of subjects | 500 | 598 | 212 |
| Sex | 500 M/0 F | 598 M/0 F | 212 M/0 F |
| Age, y | 36.0 ± 9.3 (20–58) | 35.1 ± 8.3 (18–56) | 30.5 ± 7.7 (18–56) |
| BMI, kg/m2 | 25.3 ± 3.2 | 23.2 ± 3.3 | 23.9 ± 3.9 |
| Duration of Heroin-use, mo | NA | 99.0 ± 64.6 (24–420) | 17.4 ± 7.3 (1–24) |
Figure 3The albumin (Alb, A), triglyceride (Tg, B), and total cholesterol (Tc, C) levels were decreased with the elongation of heroin use, with short-HDPs significantly lower than HCs and long-HDPs significantly lower than short-HDPs.
Figure 4Transcriptome-sequencing analysis of 16 HDPs and 25 healthy controls. (A) The t-SNE projection showed that the whole transcriptome profiles of HDPs were distinct from those of HCs. (B) The unsupervised hierarchical clustering of whole transcriptome profiles showed that the group of HDPs were separated from HCs. (C) Top differentially expressed genes between HDPs and HCs were present in a heatmap. (D–F) DAVID Biological Process and KEGG pathway analyses of differentially expressed genes between HDPs and HCs.
Figure 5Transcriptome-sequencing analysis of HDPs, SCA2 and PTSD patients versus their healthy controls. (A–B) Venn diagram of overlapping differentially expressed genes in HDPs, SCA2 and PTSD patients versus their healthy controls. (C) Top differentially expressed genes in HDPs, SCA2 and PTSD patients versus their healthy controls were present in a heatmap. (D–E) DAVID Biological Process and KEGG pathway analyses of differentially expressed genes commonly identified in HDPs, SCA2 and PTSD patients versus their healthy controls.